-
Acta Neurol. Scand. · Dec 2020
Meta AnalysisCannabidiol efficacy independent of clobazam: Meta-analysis of four randomized controlled trials.
- Orrin Devinsky, Elizabeth A Thiele, Stephen Wright, Daniel Checketts, Gilmour Morrison, Eduardo Dunayevich, and Volker Knappertz.
- Comprehensive Epilepsy Center, New York University Langone Medical Center, New York, NY, USA.
- Acta Neurol. Scand. 2020 Dec 1; 142 (6): 531-540.
ObjectiveThe efficacy of cannabidiol (CBD) with and without concomitant clobazam (CLB) was evaluated in stratified analyses of four large randomized controlled trials, two in Lennox-Gastaut syndrome, and two in Dravet syndrome.MethodsEach trial of CBD (Epidiolex® in the US; Epidyolex® in the EU; 10 and 20 mg/kg/day) was evaluated by CLB use. The treatment ratio was analyzed using negative binomial regression for changes in seizure frequency and logistic regression for the 50% responder rate, where the principle analysis combined both indications and CBD doses in a stratified meta-analysis. Pharmacokinetic data were examined for an exposure/response relationship based on CLB presence/absence. Safety data were analyzed using descriptive statistics.ResultsThe meta-analysis favored CBD vs. placebo regardless of CLB use. The treatment ratio (95% CI) of CBD over placebo for the average reduction in seizure frequency was 0.59 (0.52, 0.68; P < .0001) with CLB and 0.85 (0.73, 0.98; P = .0226) without CLB, and the 50% responder rate odds ratio (95% CI) was 2.51 (1.69, 3.71; P < .0001) with CLB and 2.40 (1.38, 4.16; P = .0020) without CLB. Adverse events (AEs) related to somnolence, rash, pneumonia, or aggression were more common in patients with concomitant CLB. There was a significant exposure/response relationship for CBD and its active metabolite.ConclusionsThese results indicate CBD is efficacious with and without CLB, but do not exclude the possibility of a synergistic effect associated with the combination of agents. The safety and tolerability profile of CBD without CLB show a lower rate of certain AEs than with CLB.© 2020 The Authors. Acta Neurologica Scandinavica published by John Wiley & Sons Ltd.
Notes
Knowledge, pearl, summary or comment to share?